Victory Capital Management Inc. Acquires 3,063 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Victory Capital Management Inc. increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) by 27.0% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 14,407 shares of the company’s stock after purchasing an additional 3,063 shares during the quarter. Victory Capital Management Inc.’s holdings in LifeStance Health Group were worth $71,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of LFST. TD Asset Management Inc acquired a new stake in LifeStance Health Group in the second quarter worth $623,000. Vanguard Group Inc. boosted its position in shares of LifeStance Health Group by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock worth $47,318,000 after purchasing an additional 95,197 shares in the last quarter. GSA Capital Partners LLP grew its stake in shares of LifeStance Health Group by 161.6% in the 1st quarter. GSA Capital Partners LLP now owns 69,492 shares of the company’s stock valued at $429,000 after buying an additional 42,932 shares during the period. Bayesian Capital Management LP acquired a new stake in shares of LifeStance Health Group in the 1st quarter valued at about $238,000. Finally, Swiss National Bank increased its position in LifeStance Health Group by 25.4% in the 1st quarter. Swiss National Bank now owns 186,800 shares of the company’s stock valued at $1,153,000 after buying an additional 37,800 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on LFST. UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. Barclays cut their target price on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $8.25.

Read Our Latest Research Report on LifeStance Health Group

LifeStance Health Group Stock Performance

Shares of LifeStance Health Group stock opened at $6.94 on Wednesday. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $9.20. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20. The business has a 50 day moving average price of $6.11 and a 200-day moving average price of $6.01. The company has a market cap of $2.65 billion, a PE ratio of -14.46 and a beta of 1.22.

LifeStance Health Group (NASDAQ:LFSTGet Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The business had revenue of $312.30 million during the quarter, compared to analyst estimates of $305.85 million. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. LifeStance Health Group’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.13) EPS. Equities analysts anticipate that LifeStance Health Group, Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Ann Varanakis sold 5,269 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $6.28, for a total transaction of $33,089.32. Following the transaction, the insider now directly owns 263,007 shares in the company, valued at $1,651,683.96. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 6.60% of the stock is currently owned by corporate insiders.

LifeStance Health Group Company Profile

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Featured Articles

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report).

Institutional Ownership by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.